Francisco Javier Guzman-de la Garza

Dr. Francisco Javier Guzman-de la Garza

orcid

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 April 2010 in Neuroimmunomodulation
Verified
Journal Article
Closed access
CCCarlos Rodrigo Cámara-Lemarroy
Carlos Rodrigo Cámara-Lemarroy
FGFrancisco Javier Guzman-de la Garza
Francisco Javier Guzman-de la Garza
NFNancy Esthela Fernández-Garza
Nancy Esthela Fernández-Garza
Wallerian degeneration, the self-destructive set of cellular and molecular processes by which degenerating axons and myelin are cleared after injury, is initiated by macrophages and Schwann cells. Molecular inflammatory mediators such as cytokines (IL-1, IL-6, IL-10, and TNF-α, among others), transcription factors (NF-ĸB, c-Jun), the complement system and arachidonic acid metabolites have been shown to modulate these processes in various studies. However, the exact role that each of these mediators plays during axonal degeneration and regeneration has not been fully established. Understanding the molecular basis of these interactions between the immune system and peripheral nerve injury would open the possibility of targeting these inflammatory mediators as therapeutic interventions. In this review we attempt to integrate the current evidence generated around this issue, and to explore the therapeutic possibilities that arise.

1 July 2013 in Clinics
Verified
Journal Article
Open access
FGFrancisco Javier Guzman-de la Garza
Francisco Javier Guzman-de la Garza
JIJuan Manuel Ibarra-Hernández
Juan Manuel Ibarra-Hernández
PCPaula Cordero-Pérez
Paula Cordero-Pérez
PVPablo Villegas-Quintero
Pablo Villegas-Quintero
CVClaudia Ivette Villarreal-Ovalle
Claudia Ivette Villarreal-Ovalle
JCJosé Gerardo Carrillo-Arriaga
José Gerardo Carrillo-Arriaga
It is essential to identify a serological marker of injury in order to study the pathophysiology of intestinal ischemia reperfusion. In this work, we studied the evolution of several serological markers after intestinal ischemia reperfusion injury in rats. The markers of non-specific cell damage were aspartate aminotransferase, alanine aminotransaminase, and lactic dehydrogenase, the markers of inflammation were tumor necrosis factor alpha, interleukin-6, and interleukin-1 beta, and the markers of intestinal mucosal damage were intestinal fatty acid binding protein and D-lactate. We used Chiús classification to grade the histopathological damage. We studied 35 Wistar rats divided into groups according to reperfusion time. The superior mesenteric artery was clamped for 30 minutes, and blood and biopsies were collected at 1, 3, 6, 12, 24, and 48 hours after reperfusion. We plotted the mean ± standard deviation and compared the baseline and maximum values for each marker using Student's t-test. The maximum values of interleukin-1 beta and lactic dehydrogenase were present before the maximal histopathological damage. The maximum tumor necrosis factor alpha and D-lactate expressions coincided with histopathological damage. Alanine aminotransaminase and aspartate aminotransferase had a maximum expression level that increased following the histopathological damage. The maximum expressions of interluken-6 and intestinal fatty acid binding protein were not significantly different from the Sham treated group. For the evaluation of injury secondary to acute intestinal ischemia reperfusion with a 30 minute ischemia period, we recommend performing histopathological grading, quantification of D-lactate, which is synthesized by intestinal bacteria and is considered an indicator of mucosal injury, and quantification of tumor necrosis factor alpha as indicators of acute inflammation three hours after reperfusion.

1 January 2008 in World Journal of Gastroenterology
Verified
Journal Article
Open access
CCCarlos Rodrigo Cámara
Carlos Rodrigo Cámara
FGFrancisco Javier Guzman-de la Garza
Francisco Javier Guzman-de la Garza
EBErnesto Alexis Barrera
Ernesto Alexis Barrera
ACAndrés Jesús Cabello
Andrés Jesús Cabello
AGArmando Garcia
Armando Garcia
JAJesus Ancer
Jesus Ancer
Ketamine anesthesia reduces intestinal ischemia/reperfusion injury in rats

21 May 2018 in Acta Neurologica Belgica
Verified
Journal Article
Closed access
PDF file
CCCarlos R. Camara-Lemarroy
Carlos R. Camara-Lemarroy
NENicolás Escobedo-Zúñiga
Nicolás Escobedo-Zúñiga
FGFrancisco Javier Guzman-de la Garza
Francisco Javier Guzman-de la Garza
JGJorge Castro Garza
Jorge Castro Garza
JVJavier Vargas-Villarreal
Javier Vargas-Villarreal
FGFernando Góngora-Rivera
Fernando Góngora-Rivera

21 June 2019 in PeerJ
Verified
Journal Article
Open access
PDF file
MPMarlene Marisol Perales-Quintana
Marlene Marisol Perales-Quintana
ASAlma L. Saucedo
Alma L. Saucedo
JLJuan Ricardo Lucio-Gutiérrez
Juan Ricardo Lucio-Gutiérrez
NWNoemí Waksman
Noemí Waksman
GAGabriela Alarcon-Galvan
Gabriela Alarcon-Galvan
PCPaula Cordero-Pérez
Paula Cordero-Pérez
Background: Renal diseases represent a major public health problem. The demonstration that maladaptive repair of acute kidney injury (AKI) can lead to the development of chronic kidney disease (CKD) and end-stage renal disease has generated interest in studying the pathophysiological pathways involved. Animal models of AKI–CKD transition represent important tools to study this pathology. We hypothesized that the administration of multiple doses of folic acid (FA) would lead to a progressive loss of renal function that could be characterized through biochemical parameters, histological classification and nuclear magnetic resonance (NMR) profiling.Methods: Wistar rats were divided into groups: the control group received a daily intraperitoneal (I.P.) injection of double-distilled water, the experimental group received a daily I.P. injection of FA (250 mg kg body weight−1). Disease was classified according to blood urea nitrogen level: mild (40–80 mg dL−1), moderate (100–200 mg dL−1) and severe (>200 mg dL−1). We analyzed through biochemical parameters, histological classification and NMR profiling.Results: Biochemical markers, pro-inflammatory cytokines and kidney injury biomarkers differed significantly (P< 0.05) between control and experimental groups. Histology revealed that as damage progressed, the degree of tubular injury increased, and the inflammatory infiltrate was more evident. NMR metabolomics and chemometrics revealed differences in urinary metabolites associated with CKD progression. The main physiological pathways affected were those involved in energy production and amino-acid metabolism, together with organic osmolytes. These data suggest that multiple administrations of FA induce a reproducible model of the induction of CKD. This model could help to evaluate new strategies for nephroprotection that could be applied in the clinic.

1 October 2009 in European Journal of Pharmacology
Verified
Journal Article
Closed access
CCCarlos Rodrigo Cámara-Lemarroy
Carlos Rodrigo Cámara-Lemarroy
FGFrancisco Javier Guzman-de la Garza
Francisco Javier Guzman-de la Garza
GAGabriela Alarcón-Galván
Gabriela Alarcón-Galván
PCPaula Cordero-Pérez
Paula Cordero-Pérez
NFNancy Esthela Fernández-Garza
Nancy Esthela Fernández-Garza